Tech Talks with Holly Scott

Guest: David Constantine

27 min · 23. Aug. 2024
Episode Guest: David Constantine Cover

Beschreibung

Neuromodulation is a rapidly growing market, with significant investments in pelvic health, including Boston Scientific's $3.4 billion acquisition of Axonics and funding for Amber Therapeutics, Neuspera Medical, and Avation Medical. David Constantine, Co-Founder and CEO of Juniper Biomedical, has leveraged his career experiences to drive their mission of revolutionizing pelvic health through precision neuromodulation. His passion for impactful work highlights the importance of finding meaningful career paths that motivate and sustain us through challenges. This conversation with David underscored the timely relevance of their innovative approach in transforming patient outcomes.

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der Tech Talks with Holly Scott-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar.

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

22 Folgen